Holly Wobma
Holly completed an MD-PhD at Columbia University in New York during which she conducted graduate training in the lab of Gordana Vunjak-Novakovic and helped co-found a cell therapy company called Immplacate. She will soon be starting (June 2019) as a pediatric resident at the Boston Combined Residency Program and is interested in developing and translating cell and gene therapies for pediatric disease.
Posts by: Holly
Redefining a cure: What a stem cell therapy for HIV reminds us about clinical translation
With over 34 million people living with HIV, of which only the fortunate have continual access to life-saving anti-retroviral drugs, it comes as no surprise that the recent media announcement of a potential “cure” for HIV went rapidly…well…viral. The excitement spurred from the XIX International AIDS Conference held in Washington DC (July 22-27, 2012) during […]
If Gandhi were a stem cell, which would he be?
My guess…is an HSC (hematopoietic stem cell). Because although these cells aren’t known for their civil disobedience, they do have a certain knack for making people more tolerant. In fact, that’s why Dr. Megan Sykes, Director of the Columbia Center for Translational Immunology, finds them so interesting. She wants to use these cells to teach […]
Comments